Dose-response relationships can be evaluated in which phases of development?

• A. In all phases of development
• B. Only in the initial phase
• C. Only in pivotal trials
• D. Only post-marketing

Answer: (A)

Dose-response relationships describe how the magnitude of a drug’s effect changes with different doses. This analysis is useful in every stage of development. In early studies, dose-escalation helps map where responses begin and how safety risks rise with higher doses. In dose-ranging phases, you identify the dose that offers the best balance of efficacy and safety and shape the response curve. In pivotal trials, examining multiple doses supports selecting a recommended dose and shows that the effect is consistent across participants. After approval, ongoing exposure-response work with real-world data confirms the chosen dose remains appropriate across diverse populations and can reveal if labeling or recommendations need adjustment. Because dose-response information informs dosing decisions throughout development, it isn’t confined to any single phase.